Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(565/week)
Manufacturing
(380/week)
Energy
(296/week)
Technology
(385/week)
Environment
(222/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Sangamo Therapeutics, Inc.
Dec 07, 2017
Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome Editing Treatments For MPS I And MPS II
Nov 24, 2017
Sangamo Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 15, 2017
Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II
Nov 09, 2017
Sangamo Announces Strategic Investment In Manufacturing And Appointment Of Andy Ramelmeier As Head Of Technical Operations
Nov 09, 2017
Sangamo Therapeutics Reports Third Quarter 2017 Financial Results
Oct 31, 2017
Sangamo Therapeutics Announces Third Quarter 2017 Conference Call And Webcast
Oct 17, 2017
Sangamo Therapeutics Announces Presentations At 2017 Annual Congress Of The European Society Of Gene And Cell Therapy
Oct 02, 2017
Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Beta-Thalassemia
Sep 28, 2017
Sangamo Therapeutics Announces Participation At Upcoming Investor And Industry Conferences
Sep 20, 2017
Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference
Aug 31, 2017
Sangamo Presents T Cell Engineering Capabilities at Immuno-Oncology Summit
Aug 30, 2017
Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences
Aug 25, 2017
Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A
Aug 10, 2017
Sangamo Therapeutics Announces Presentation At The 2017 Wedbush PacGrow Healthcare Conference
Aug 09, 2017
Sangamo Therapeutics Reports Second Quarter 2017 Financial Results
Aug 02, 2017
Sangamo Therapeutics Announces Second Quarter 2017 Conference Call And Webcast
Jul 13, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II
Jun 29, 2017
Sangamo Therapeutics Appoints Roger Jeffs, Ph.D. and Joseph S. Zakrzewski to its Board of Directors
Jun 20, 2017
Sangamo Therapeutics Announces Proposed Public Offering of Common Stock
Jun 07, 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
‹‹
Page 4
››
Latest News
Apr 23, 2024
Shippeo Spring Platform Release Reveals All-new Parcel Tracking, Advanced Carbon Emissions Monitoring...
Apr 23, 2024
LaPhair Capital Partners Acquires Kinexx Modular Construction to Accelerate Homeownership in Urban Communities
Apr 23, 2024
Edge Impulse Brings Industrial Computer Vision Breakthroughs in Anomaly Detection to Any Edge Device for the...
Apr 23, 2024
Faraday Future Announces Werner Wilhelm as Executive Launch Director
Apr 23, 2024
Nidec Announces Financial Results for Fiscal Year Ended March 31, 2024
Apr 23, 2024
Popular uMhlanga Rocks Whalebone Pier in South Africa Gets a New Lease on Life with Penetron Technology
Apr 23, 2024
EverGen Infrastructure Reports Q4 & Year End 2023 Results
Apr 23, 2024
Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2024
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events